Cart
sales@molnova.com
Triflusal
CAS No. 322-79-2
Triflusal( Triflusal, Disgren, Grendis, Aflen, Triflux )
Catalog No. M14050 CAS No. 322-79-2
Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 58 | In Stock |
|
| 25MG | 106 | In Stock |
|
| 50MG | 177 | In Stock |
|
| 100MG | 295 | In Stock |
|
| 200MG | 444 | In Stock |
|
| 500MG | 710 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTriflusal
-
NoteResearch use only, not for human use.
-
Brief DescriptionTriflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.
-
DescriptionTriflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA).
-
In Vitro——
-
In Vivo——
-
SynonymsTriflusal, Disgren, Grendis, Aflen, Triflux
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE| TXA2R
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number322-79-2
-
Formula Weight248.16
-
Molecular FormulaC10H7F3O4
-
Purity>98% (HPLC)
-
SolubilityEthanol: 50 mg/mL (201.48 mM); DMSO: 50 mg/mL (201.48 mM)
-
SMILESO=C(O)C1=CC=C(C(F)(F)F)C=C1OC(C)=O
-
Chemical Name2-acetyloxy-4-(trifluoromethyl)benzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Acta Crystallographica Section A, 49 ( Pt 1), 10-22 (1993)
molnova catalog
related products
-
Cilostazol
Cilostazol (OPC 13013, OPC 21) is a potent inhibitor of PDE3A with IC50 of 0.2 uM; inhibits platelet aggregation and has considerable antithrombotic effects in vivo.
-
Dasantafil
Dasantafil (SCH446132) is a small molecule phosphodiesterase-5A (PDE5A) inhibitor used to treat genitourinary disorders and study erectile dysfunction.
-
Tofimilast
Tofimilast (CP-325366) is a potent, selective PDE4 inhibitor with IC50 of 23, 13 and 13 nM for PDE4A, PDE4B, and PDE4D, respectively.
